Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial.
Larissa OteroN ZetolaM CamposJ ZuntA BayerM CurisincheT OchoaM ReyesV VegaP Van der StuyftT R SterlingPublished in: Trials (2023)
ClinicalTrials.gov NCT03881228. Registered on March 19, 2019.
Keyphrases
- phase iii
- mycobacterium tuberculosis
- phase ii
- open label
- double blind
- clinical trial
- placebo controlled
- young adults
- study protocol
- pulmonary tuberculosis
- hiv aids
- randomized controlled trial
- emergency department
- mesenchymal stem cells
- adverse drug
- bone marrow
- hiv infected
- hepatitis c virus
- drug induced
- replacement therapy